FULC
Fulcrum Therapeutics, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-02-24
Figures on this page computed 2026-11-08 12:40 UTC
Last close
3.77USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-02-24
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-065197
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-02-24
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-065197
- Reported in
- USD
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
- 10-Q for 2025, filed 2026-07-30
- 10-K for 2025, filed 2026-02-24
- 10-Q for 2025, filed 2026-07-30
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-065197
- Reported in
- USD
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-065197
- Reported in
- USD
- 10-K for 2025, filed 2026-02-24
- 10-K for 2025, filed 2026-02-24
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001193125-26-065197
- Reported in
- USD
- 10-K for 2025, filed 2026-02-24
- 10-Q for 2025, filed 2026-07-30
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Growth is the furthest below its sector's middle: 0.02 against 0.50 on the market's range.
- Growth-100.0%2 of 100, below its sector
- Returns on capital-21.5%26 of 100, above its sector
- Marginsn/anot placed
- Price0.8x76 of 100, above its sector
- Safety27.4094 of 100, above its sector
- What it pays outn/anot placed
- Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Ten years as a story
lens 9 of 9Every filing we hold, oldest first
8- 2020-03-05Annual report for 201810-K
- 2020-03-05Annual report for 201910-K
- 2021-03-04Annual report for 202010-K
- 2022-03-03Annual report for 202110-K
- 2023-03-09Annual report for 202210-K
- 2024-02-27Annual report for 202310-K
- 2025-02-25Annual report for 202410-K
- 2026-02-24Annual report for 202510-K
8 filings over the years we hold, each pinned to the day it landed.
8 filings over the years we hold, each pinned to the day it landed.